Purchases and Sales Made in Q3 2024 in Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX) during Q3 2024. The information is specifically focused on institutions that hold shares of VERTEX PHARMACEUTICALS INC .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-444K- 20.06% |
$204M - $224M
|
1.77M
$816M
|
|
|
Nov 14, 2024
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-545K- 36.73% |
$251M - $275M
|
938K
$433M
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-704K- 34.13% |
$324M - $356M
|
1.36M
$627M
|
|
|
Nov 04, 2024
Q3 2024
|
Mayflower Financial Advisors, LLC
|
SELL
|
- |
-728K- 99.8% |
$335M - $368M
|
1.48K
$684K
|